药研通(参比购)-免费查询参比制剂目录,一站式代理进口全球参比制剂。
仿制药参比制剂目录(第二十一批)
序号 |
药品通用名称 | 英文名称/商品名 | 规格 | 剂型 | 持证商 | 备注1 | 备注2 | |
|---|---|---|---|---|---|---|---|---|
21-101 |
注射用环磷酰胺 |
Cyclophosphamide for Injection/Endoxan(安道生) |
0.2g |
注射剂 |
Baxter Oncology GmbH/Baxter Deutschland GmbH |
国内上市的原研药品 |
||
21-102 |
注射用环磷酰胺 |
Cyclophosphamide for Injection/Endoxan(安道生) |
1g |
注射剂 |
Baxter Oncology GmbH/Baxter Deutschland GmbH |
国内上市的原研药品 |
||
21-103 |
注射用盐酸吉西他滨 |
Gemcitabine Hydrochloride for Injection/Gemzar(健择) |
200 mg(以C9H11F2N3O4计) |
注射剂 |
LILLY France |
国内上市的原研药品 |
||
21-104 |
注射用盐酸吉西他滨 |
Gemcitabine Hydrochloride for Injection/Gemzar(健择) |
1g(以C9H11F2N3O4计) |
注射剂 |
LILLY France |
国内上市的原研药品 |
||
21-105 |
醋酸加尼瑞克注射液 |
Ganirelix Injection/ORGALUTRAN(欧加利) |
0.5ml:0.25mg(以加尼瑞克计) |
注射剂 |
Merck Sharp & Dohme Limited / Merck Sharp & Dohme B. V./N.V. Organon |
国内上市的原研药品 |
||
21-106 |
糠酸氟替卡松维兰特罗吸入粉雾剂(II) |
Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation(II)/RELVAR(万瑞舒) |
糠酸氟替卡松100μg与三苯乙酸维兰特罗(以维兰特罗计)25μg |
吸入制剂 |
Glaxo Group Limited |
国内上市的原研药品 |
||
21-107 |
糠酸氟替卡松维兰特罗吸入粉雾剂(III) |
Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation(III)/RELVAR(万瑞舒) |
糠酸氟替卡松200μg与三苯乙酸维兰特罗(以维兰特罗计)25μg |
吸入制剂 |
Glaxo Group Limited |
国内上市的原研药品 |
||
21-108 |
糠酸莫米松富马酸福莫特罗吸入气雾剂 |
Mometasone Furoate and Formoterol Fumarate Dihydrate/ DULERA |
0.005mg/0.1mg |
吸入气雾剂 |
MERCK SHARP AND DOHME CORP |
未进口原研药品 |
||
21-109 |
糠酸莫米松富马酸福莫特罗吸入气雾剂 |
Mometasone Furoate and Formoterol Fumarate Dihydrate/ DULERA |
0.005mg/0.2mg |
吸入气雾剂 |
MERCK SHARP AND DOHME CORP |
未进口原研药品 |
||
21-110 |
富马酸福莫特罗吸入溶液 |
Formoterol Fumarate Inhalation Solution/PERFOROMIST |
0.02mg/2ml |
吸入用溶液剂 |
MYLAN SPECIALTY LP |
未进口原研药品 |
||
21-111 |
沙美特罗替卡松吸入粉雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation/Seretide(舒利迭) |
50ug/100ug/泡 |
干粉吸入剂 |
Laboratoire GlaxoSmithKline |
国内上市的原研药品 |
||
21-112 |
沙美特罗替卡松吸入粉雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation/Seretide(舒利迭) |
50ug/250ug/泡 |
干粉吸入剂 |
Laboratoire GlaxoSmithKline |
国内上市的原研药品 |
||
21-113 |
沙美特罗替卡松吸入粉雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation/Seretide(舒利迭) |
50ug/500ug/泡 |
干粉吸入剂 |
Laboratoire GlaxoSmithKline |
国内上市的原研药品 |
||
21-114 |
沙美特罗替卡松吸入气雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Inhalation Aerosol/Seretide(舒利迭) |
25ug/50ug/揿 |
气雾剂 |
GlaxoSmithKline Australia Pty Ltd |
国内上市的原研药品 |
||
21-115 |
沙美特罗替卡松吸入气雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Inhalation Aerosol/Seretide(舒利迭) |
25ug/250ug/揿 |
气雾剂 |
GlaxoSmithKline Australia Pty Ltd |
国内上市的原研药品 |
||
21-116 |
沙美特罗替卡松吸入气雾剂 |
Salmeterol Xinafoate and Fluticasone Propionate Aerosol/Seretide(舒利迭) |
25ug/125ug/揿 |
气雾剂 |
Laboratoire GlaxoSmithKline |
国内上市的原研药品 |
||
21-117 |
拉坦前列素滴眼液 |
Latanoprost Eye Drops/Xalatan(适利达) |
2.5ml:125µg |
滴眼剂 |
PFIZER SA/Upjohn SRL/BV/Viatris GX |
国内上市的原研药品 |
||
21-118 |
注射用兰索拉唑 |
Lansoprazole For Injection/Takepron |
30mg |
注射剂 |
武田薬品工業株式会社 |
未进口原研药品 |
||
21-119 |
注射用硼替佐米 |
Bortezomib For Injection/Velcade(万珂) |
1.0mg |
注射剂 |
Janssen-Cilag International N. V. |
国内上市的原研药品 |
||
21-120 |
注射用硼替佐米 |
Bortezomib For Injection/Velcade(万珂) |
3.5mg |
注射剂 |
Janssen-Cilag International N. V. |
国内上市的原研药品 |
||
21-121 |
醋酸去氨加压素注射液 |
Desmopressin Acetate Injection/Minirin(弥柠) |
1mL:4μg(按去氨加压素计3.56μg) |
注射剂 |
Ferring AG |
国内上市的原研药品 |
||
21-122 |
醋酸去氨加压素注射液 |
Desmopressin Acetate Injection/Octostim(依他停) |
1mL:15μg(按去氨加压素计13.4μg) |
注射剂 |
Ferring AG |
国内上市的原研药品 |
||
21-123 |
瑞加诺生注射液 |
Regadenoson Injection/LEXISCAN |
5mL:0.4mg |
注射剂 |
ASTELLAS PHARMAUS INC |
未进口原研药品 |
||
21-124 |
注射用帕瑞昔布钠 |
Parecoxib Sodium for Injection/Dynastat(特耐) |
40mg |
注射剂 |
Pfizer Ltd. |
国内上市的原研药品 |
||
21-125 |
注射用泮托拉唑钠 |
Pantoprazole sodium for injection/Pantoloc(潘妥洛克) |
40mg/瓶 |
注射剂 |
Takeda GmbH |
国内上市的原研药品 |
||
21-126 |
盐酸屈他维林注射液 |
Drotaverine Hydrochloride Injection/NO-SPA(诺仕帕) |
2ml:40mg |
注射剂 |
Sanofi-aventis Private Co.Ltd./ Opella Healthcare Commercial Ltd. |
国内上市的原研药品 |
||
21-127 |
咪达唑仑注射液 |
Midazolam Injection/Dormicum |
5mg:5ml |
注射剂 |
Roche Pharma(Suisse)SA / CPS Cito Pharma Services GmbH |
未进口原研药品 |
||
21-128 |
咪达唑仑注射液 |
Midazolam Injection/Dormicum |
5mg:1ml |
注射剂 |
Roche Pharma(Suisse) SA / CPS Cito Pharma Services GmbH |
未进口原研药品 |
||
21-129 |
咪达唑仑注射液 |
Midazolam Injection/Dormicum |
15mg:3ml |
注射剂 |
Roche Pharma(Suisse) SA / CPS Cito Pharma Services GmbH |
未进口原研药品 |
||
21-130 |
咪达唑仑注射液 |
Midazolam Injection/Dormicum |
50mg:10ml |
注射剂 |
Roche Pharma(Suisse)SA / CPS Cito Pharma Services GmbH |
未进口原研药品 |
||
21-131 |
咪达唑仑注射液 |
Midazolam Injection/Hypnovel |
10mg:2ml |
注射剂 |
Roche Products Limited / Cheplapharma Arzneimittel GmbH |
未进口原研药品 |
||
21-132 |
咪达唑仑口颊粘膜溶液 |
Midazolam Oromucosal Solution/BUCCOLAM |
2.5mg:0.5ml |
口服溶液剂 |
Shire Services BVBA/Neuraxpharm Pharmaceuticals S.L. |
未进口原研药品 |
||
21-133 |
咪达唑仑口颊粘膜溶液 |
Midazolam Oromucosal Solution/BUCCOLAM |
5mg:1ml |
口服溶液剂 |
Shire Services BVBA/Neuraxpharm Pharmaceuticals S.L. |
未进口原研药品 |
||
21-134 |
咪达唑仑口颊粘膜溶液 |
Midazolam Oromucosal Solution/BUCCOLAM |
7.5mg:1.5ml |
口服溶液剂 |
Shire Services BVBA/Neuraxpharm Pharmaceuticals S.L. |
未进口原研药品 |
||
21-135 |
咪达唑仑口颊粘膜溶液 |
Midazolam Oromucosal Solution/BUCCOLAM |
10mg:2ml |
口服溶液剂 |
Shire Services BVBA/Neuraxpharm Pharmaceuticals S.L. |
未进口原研药品 |
||
21-136 |
咪达唑仑口服溶液 |
Midazolam Hydrochloride Syrup |
2mg/ml(236mg:118ml) |
口服溶液剂 |
WEST-WARD PHARMACEUTICALSINTERNATIONAL LTD |
原研撤市,推荐美国上市的国际公认的同种药品 |
||
21-137 |
盐酸羟考酮注射液 |
Oxycodone Hydrochloride Injection/- |
1mL:10mg |
注射剂 |
Napp Pharmaceuticals Limited |
国内上市的原研药品 |
||
21-138 |
盐酸羟考酮注射液 |
Oxycodone Hydrochloride Injection/- |
2mL:20mg |
注射剂 |
Napp Pharmaceuticals Limited |
国内上市的原研药品 |
||
21-139 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection/Nimbex(赛机宁) |
2.5mL:5mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited/Aspen Pharmacare Australia Pty Ltd |
国内上市的原研药品 |
||
21-140 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection/Nimbex(赛机宁) |
5mL:10mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited/Aspen Pharmacare Australia Pty Ltd |
国内上市的原研药品 |
||
21-141 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection/Nimbex(赛机宁) |
10mL:20mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited/Aspen Pharmacare Australia Pty Ltd |
国内上市的原研药品 |
||
21-142 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta Preservative Free |
EQ0.05MG BASE/ML(1mL:50µg) |
注射剂 |
Akorn Inc |
未进口原研药品 |
||
21-143 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta Forte |
1mL:50µg |
注射剂 |
Janssen-Cilag/PiramalCritical Care Limited/Piramal Critical Care B.V. |
未进口原研药品 |
||
21-144 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta Preservative Free |
EQ0.05MG BASE/ML(2mL:100µg) |
注射剂 |
Akorn Inc |
未进口原研药品 |
||
21-145 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta Preservative Free |
EQ0.05MG BASE/ML(5mL:250µg) |
注射剂 |
Akorn Inc |
未进口原研药品 |
||
21-146 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta Forte |
5mL:250µg |
注射剂 |
Janssen-Cilag/Piramal Critical Care Limited/ Piramal Critical Care B.V. |
未进口原研药品 |
||
21-147 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta |
10mL:50μg |
注射剂 |
Janssen-Cilag/Piramal Critical Care Limited/ Piramal Critical Care B.V. |
未进口原研药品 |
||
21-148 |
枸橼酸舒芬太尼注射液 |
Sufentanil Citrate Injection/Sufenta |
2mL:10μg |
注射剂 |
Janssen-Cilag/Piramal Critical Care Limited/ Piramal Critical Care B.V. |
未进口原研药品 |
||
21-149 |
米库氯铵注射液 |
Mivacurium Chloride Injection/Mivacron(美维松) |
5mL:10mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited |
国内上市的原研药品 |
||
21-150 |
米库氯铵注射液 |
Mivacurium Chloride Injection/Mivacron(美维松) |
10mL:20mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited |
国内上市的原研药品 |
||
21-151 |
糠酸莫米松鼻喷雾剂 |
Mometasone Furoate Aqueous Nasal Spray/ Nasonex(内舒拿) |
50μg/揿(0.05%) |
鼻喷雾剂 |
MSD Belgium BVBA/SPRL |
国内上市的原研药品 |
||
21-152 |
尼莫地平口服溶液 |
Nimodipine Oral Solution/NYMALIZE |
60mg/20ml |
口服溶液剂 |
Arbor Pharmaceuticals, LLC |
未进口原研药品 |
||
21-153 |
注射用培美曲塞二钠 |
Pemetrexed Disodium for Injection/Alimta(力比泰) |
100mg(以C20H21N5O6计) |
注射剂 |
Eli Lilly And Company/Eli Lilly Nederland B.V. |
国内上市的原研药品 |
||
21-154 |
注射用培美曲塞二钠 |
Pemetrexed Disodium for Injection/Alimta(力比泰) |
500mg(以C20H21N5O6计) |
注射剂 |
Eli Lilly And Company/Eli Lilly Nederland B.V. |
国内上市的原研药品 |
||
21-155 |
注射用头孢米诺钠 |
Cefminox Sodium for Injection/Meicelin(美士灵) |
1.0g(以C16H21N7O7S3计) |
注射剂 |
Meiji Seika Pharma Co., Ltd |
国内上市的原研药品 |
||
21-156 |
注射用美罗培南 |
Meropenem For Injection/Mepem(美平) |
0.25g |
注射剂 |
Sumitomo Dainippon Pharma Co.,Ltd. |
国内上市的原研药品 |
||
21-157 |
注射用美罗培南 |
Meropenem For Injection/Mepem(美平) |
0.5g |
注射剂 |
Sumitomo Dainippon Pharma Co.,Ltd./ Sumitomo Pharma Co., Ltd. |
国内上市的原研药品 |
||
21-158 |
注射用哌拉西林钠他唑巴坦钠 |
Piperacillin Sodium And Tazobactam Sodium For Injection/Tazocin(特治星) |
4.5g |
注射剂 |
Pfizer Limited |
国内上市的原研药品 |
||
21-159 |
盐酸莫西沙星氯化钠注射液 |
Moxifloxacin Hydrochloride And Sodium Chloride Injection/Avelox(拜复乐) |
250mL:莫西沙星0.4g与氯化钠2.0g |
注射剂 |
Bayer Vital GmbH |
国内上市的原研药品 |
原研进口 |
|
21-160 |
吸入用硫酸沙丁胺醇溶液 |
Salbutamol Sulfate Inhalation Solution/Ventolin Nebules |
5mg/2.5mL |
吸入用溶液剂 |
GlaxoSmithkline Australia Pty Ltd. |
国内上市的原研药品 |
||
21-161 |
吸入用复方异丙托溴铵溶液 |
Compound Ipratropium Bromide Solution For Inhalation/Combivent |
2.5mL/支 |
吸入用溶液剂 |
SCS Boehringer Ingelheim Comm. V/Boehringer Ingelheim Scomm |
国内上市的原研药品 |
||
21-162 |
硫酸特布他林雾化吸入用溶液 |
Terbutaline Sulphate Solution for Nebulization/Bricanyl(博利康尼) |
2mL:5mg |
雾化溶液剂 |
AstraZeneca AB |
国内上市的原研药品 |
||
21-163 |
注射用替加环素 |
Tigecycline for Injection/Tygacil(泰阁) |
50mg |
注射剂 |
Pfizer Limited/Pfizer Europe MA EEIG |
国内上市的原研药品 |
||
21-164 |
盐酸伊立替康注射液 |
Irinotecan Hydrochloride Injection/Campto(开普拓) |
2mL:40mg |
注射剂 |
Pfizer Australia Pty Ltd |
国内上市的原研药品 |
||
21-165 |
盐酸伊立替康注射液 |
Irinotecan Hydrochloride Injection/Campto(开普拓) |
15mL:0.3g |
注射剂 |
Pfizer Australia Pty Ltd |
国内上市的原研药品 |
||
21-166 |
盐酸伊立替康注射液 |
Irinotecan Hydrochloride Injection/Campto(开普拓) |
5mL:0.1g |
注射剂 |
Pfizer Australia Pty Ltd |
国内上市的原研药品 |
||
21-167 |
注射用紫杉醇(白蛋白结合型) |
Paclitaxel For Injection(Albumin Bound)/Abraxane |
100mg |
注射剂 |
Celgene Corporation |
国内上市的原研药品 |
||
21-168 |
利培酮口服溶液 |
Risperidone Oral Solution/Risperdal(维思通) |
0.1%(30mL:30mg) |
口服溶液剂 |
Janssen-Cilag N.V. |
国内上市的原研药品 |
||
21-169 |
利培酮口服溶液 |
Risperidone Oral Solution/Risperdal(维思通) |
0.1%(100mL:100mg) |
口服溶液剂 |
Janssen-Cilag N.V. |
国内上市的原研药品 |
||
21-170 |
盐酸美金刚口服溶液 |
Memantine Hydrochloride Oral Solution/Ebixa |
每掀0.5mL,含盐酸美金刚5mg,50mL/瓶 |
口服溶液剂 |
H.Lundbeck A/S |
未进口原研药品 |
||
21-171 |
盐酸美金刚口服溶液 |
Memantine Hydrochloride Oral Solution/Ebixa |
每掀0.5mL,含盐酸美金刚5mg,100mL/瓶 |
口服溶液剂 |
H.Lundbeck A/S |
未进口原研药品 |
||
21-172 |
棕榈帕利哌酮酯注射液(3M) |
Paliperidone Palmitate Injection(3M)/Invega Trinza(善妥达) |
按帕利哌酮(C23H27FN4O3)计0.875mL:175mg |
注射剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
21-173 |
棕榈帕利哌酮酯注射液(3M) |
Paliperidone Palmitate Injection(3M)/Invega Trinza(善妥达) |
按帕利哌酮((C23H27FN4O3)计1.315mL:263mg |
注射剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
21-174 |
棕榈帕利哌酮酯注射液(3M) |
Paliperidone Palmitate Injection(3M)/Invega Trinza(善妥达) |
按帕利哌酮(C23H27FN4O3)计1.75mL:350mg |
注射剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
21-175 |
棕榈帕利哌酮酯注射液(3M) |
Paliperidone Palmitate Injection(3M)/Invega Trinza(善妥达) |
按帕利哌酮(C23H27FN4O3)计2.625mL:525mg |
注射剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
21-176 |
他克莫司软膏 |
Tacrolimus Ointment/Protopic(普特彼) |
0.03%(10g:3mg) |
软膏剂 |
LEO Pharma A/S/Astellas Pharma Europe B.V. |
国内上市的原研药品 |
||
21-177 |
他克莫司软膏 |
Tacrolimus Ointment/Protopic(普特彼) |
0.1%(10g:10mg) |
软膏剂 |
LEO Pharma A/S/Astellas Pharma Europe B.V. |
国内上市的原研药品 |
||
21-178 |
盐酸右美托咪定注射液 |
Dexmedetomidine Hydrochloride Injection/PRECEDEX |
2mL:200μg |
注射剂 |
HOSPIRA INC |
未进口原研药品 |
||
21-179 |
盐酸右美托咪定氯化钠注射液 |
Dexmedetomidine Hydrochloride Injection/PRECEDEX |
50mL:200μg |
注射剂 |
HOSPIRA INC |
未进口原研药品 |
||
21-180 |
盐酸右美托咪定氯化钠注射液 |
Dexmedetomidine Hydrochloride Injection/PRECEDEX |
20mL:80μg |
注射剂 |
HOSPIRA INC |
未进口原研药品 |
||
21-181 |
盐酸右美托咪定氯化钠注射液 |
Dexmedetomidine Hydrochloride Injection/PRECEDEX |
100mL:400μg |
注射剂 |
HOSPIRA INC |
未进口原研药品 |
||
21-182 |
酒石酸长春瑞滨注射液 |
Vinorelbine Tartrate Injection/Navelbine(诺维本) |
1mL:10mg |
注射剂 |
Pierre Fabre Medicament |
国内上市的原研药品 |
||
21-183 |
酒石酸长春瑞滨注射液 |
Vinorelbine Tartrate Injection/Navelbine(诺维本) |
5mL:50mg |
注射剂 |
Pierre Fabre Medicament |
国内上市的原研药品 |
||
21-184 |
注射用特利加压素 |
Terlipressin for Injection/Glypressin(可利新) |
1mg |
注射剂 |
Ferring GmbH |
国内上市的原研药品 |
||
21-185 |
乌美溴铵维兰特罗吸入粉雾剂 |
Umeclidinium Bromide And Vilanterol Trifenatate Powder for Inhalation/ANORO( 欧乐欣) |
乌美溴铵(以乌美铵计)62.5μg与三苯乙酸维兰特罗(以维兰特罗计)25μg |
吸入粉雾剂 |
Glaxo Group Limited |
国内上市的原研药品 |
||
21-186 |
注射用胸腺法新 |
Thymalfasin for Injection/ZADAXIN(日达仙) |
1.6mg |
注射剂 |
SciClone Pharmaceuticals Italy S.R.L. |
国内上市的原研药品 |
||
21-187 |
溴芬酸钠滴眼液 |
Bromfenac Sodium Eye Drops/ BRONUCK(普罗纳克) |
0.1%(5mL:5mg,按C15H11BrNNaO3·1½H2O计) |
滴眼剂 |
千寿制药株式会社 |
国内上市的原研药品 |
||
21-188 |
注射用头孢他啶 |
Ceftazidime for Injection/FORTUM(复达欣) |
1g |
注射剂 |
GLAXOSMITHKLINE S.p.A. |
国内上市的原研药品 |
||
21-189 |
托拉塞米注射液 |
Torsemide Injection/Torem |
10mg:2mL |
注射剂 |
Berlin-Chemie AG |
未进口原研药品 |
||
21-190 |
托拉塞米注射液 |
Torsemide Injection/Torem |
20mg:4mL |
注射剂 |
Berlin-Chemie AG |
未进口原研药品 |
||
21-191 |
托拉塞米注射液 |
Torsemide Injection/Torem |
200mg:20mL |
注射剂 |
Berlin-Chemie AG |
未进口原研药品 |
||
21-192 |
中/长链脂肪乳注射液(C8~24 Ve) |
Medium And Long Chain Fat Emulsion/Lipofundin MCT/LCT 10%(力保肪宁) |
10%×100mL/瓶 |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
21-193 |
中/长链脂肪乳注射液(C8~24 Ve) |
Medium And Long Chain Fat Emulsion/Lipofundin MCT/LCT 10%(力保肪宁) |
10%×250mL/瓶 |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
21-194 |
中/长链脂肪乳注射液(C8~24 Ve) |
Medium And Long Chain Fat Emulsion/Lipofundin MCT/LCT 10%(力保肪宁) |
10%×500mL/瓶 |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
21-195 |
中/长链脂肪乳注射液(C8~24 Ve) |
Medium And Long Chain Fat Emulsion/Lipofundin MCT/LCT(力保肪宁) |
20%×100mL/瓶 |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
21-196 |
中/长链脂肪乳注射液(C8~24 Ve) |
Medium And Long Chain Fat Emulsion/Lipofundin MCT/LCT(力保肪宁) |
20%×250mL/瓶 |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
21-197 |
长链脂肪乳注射液(OO) |
Long Chain Fat Emulsion Injection(OO)/ClinOleic(克凌诺) |
100mL:20g(脂肪)与1.2g(磷脂) |
注射剂 |
Baxter S.A. |
国内上市的原研药品 |
||
21-198 |
长链脂肪乳注射液(OO) |
Long Chain Fat Emulsion Injection(OO)/ClinOleic(克凌诺) |
250mL:50g(脂肪)与3g(磷脂) |
注射剂 |
Baxter S.A. |
国内上市的原研药品 |
||
21-199 |
依达拉奉注射液 |
Edaravone Injection/RADICUT |
20mL:30mg |
注射剂 |
田边三菱制药株式会社 |
未进口原研药品 |
||
21-200 |
依达拉奉氯化钠注射液 |
Edaravone Injection/RADICUT |
100mL:30mg |
注射剂 |
田边三菱制药株式会社 |
未进口原研药品 |
1.网站数据库说明:本网站所有仿制药参比制剂目录数据源自国家药品监督管理局官方网站;
2.参比制剂选择原则:有原研进口的应选择原研进口药作为参比制剂首选;


